Anúncio
Anúncio
INM
InMed Pharmaceuticals Inc. Common Shares
1.30
USDPatrocinado
+0.05
+4.16%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
1.30
0.00
+0.23%
Relatórios de Lucros INM
Rácio de surpresa positiva
INM separação 2 de 7 últimas estimativas.
29%
Próximo Relatório
Data do Próximo Relatório
10 de fev. de 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/--
Mudanças implicadas de Q1 26 (Revenue/ EPS)
--
/--
Mudanças implicadas de Q2 25 (Revenue/ EPS)
--
/--
InMed Pharmaceuticals Inc. Common Shares earnings per share and revenue
On 06 de nov. de 2025, INM reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were InMed Pharmaceuticals Inc. Common Shares's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, InMed Pharmaceuticals Inc. Common Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to InMed Pharmaceuticals Inc. Common Shares's Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is InMed Pharmaceuticals Inc. Common Shares expected to report next?
The next earning report is scheduled for 10 de fev. de 2026.
What are the forecasts for InMed Pharmaceuticals Inc. Common Shares's next earnings report?
Based on --
analistas, InMed Pharmaceuticals Inc. Common Shares is expected to report EPS of -- and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio